News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Data From Genzyme Corporation (GENZ)’s Multiple Sclerosis Franchise Featured At American Academy of Neurology


4/22/2014 6:55:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that 18 poster and oral presentations featuring Aubagio® (teriflunomide) and LemtradaTM (alemtuzumab) will be presented during the 66th American Academy of Neurology (AAN) Annual Meeting to be held in Philadelphia, April 26 – May 3, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES